Advances in pharmacogenetics.
D000429:Alcohol Oxidoreductases; D002374:Catalase; D002802:Cholinesterases; D001728:Dicumarol / Q000009:adverse effects; D004200:Diseases in Twins; D004342:Drug Hypersensitivity; D004351:Drug Resistance; D064420:Drug-Related Side Effects and Adverse Reactions; D004777:Environment; D005260:Female; D030342:Genetic Diseases, Inborn / Q000188:drug therapy; D005901:Glaucoma / Q000235:genetics; D005955:Glucosephosphate Dehydrogenase Deficiency; D006454:Hemoglobins; D006801:Humans; D007231:Infant, Newborn; D007429:Intraocular Pressure / Q000187:drug effects; D007538:Isoniazid; D008305:Malignant Hyperthermia / Q000235:genetics; D009154:Mutation; D004364:Pharmaceutical Preparations / Q000097:blood / Q000378:metabolism; D010597:Pharmacogenetics; D010670:Phenylthiourea; D010672:Phenytoin / Q000378:metabolism; D011247:Pregnancy; D011485:Protein Binding; D044469:Racial Groups; D014859:Warfarin
D006454:Hemoglobins; D004364:Pharmaceutical Preparations; D014859:Warfarin; D010672:Phenytoin; D010670:Phenylthiourea; D001728:Dicumarol; D000429:Alcohol Oxidoreductases; D002374:Catalase; D002802:Cholinesterases; D007538:Isoniazid